Virtual Control

Spectrometry Industry Unlocks Growth Potentials in NMR Spectroscopy - Grand View Research, Inc.

Retrieved on: 
Wednesday, June 28, 2023
Food, GC/MS, IR, Ester, NMR, Mass spectrometry, Biotechnology, Biopharma LLC, Biomedical Research, Dicarboxylic acid, Research, Thermo Fisher Scientific, Near-infrared spectroscopy, USD, Proteomics, MS, Athlete, Nuclear magnetic resonance spectroscopy, Paint, Agilent Technologies, Acquisition, GC-MS, Investment, SAN, Drug discovery, Gas chromatography–mass spectrometry, Growth, Virtual Control, PCR, Red Data Book of Ukraine, Software, Fine chemical, Medical imaging

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Forward-looking players have upped investments in molecular spectrometry in pharmaceutical and biotechnology in the wake of innovation in infrared (IR) spectroscopy.
  • Equipment manufacturers have injected funds into mass spectrometry (MS) in the drug development pipeline, applied testing, clinical diagnostics and food products.
  • Order your copy of the Free Sample of "Spectrometry Industry Data Book - Spectrometry, Mass Spectrometry, NMR Spectroscopy, Near-Infrared Spectroscopy and In-line UV-vis Spectroscopy Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research
    An uptick in biomedical research has fueled the penetration of nuclear magnetic resonance (NMR) spectroscopy across business verticals.

Spectrometry Industry Unlocks Growth Potentials in NMR Spectroscopy - Grand View Research, Inc.

Retrieved on: 
Wednesday, June 28, 2023
Food, GC/MS, IR, Ester, NMR, Mass spectrometry, Biotechnology, Biopharma LLC, Biomedical Research, Dicarboxylic acid, Research, Thermo Fisher Scientific, Near-infrared spectroscopy, USD, Proteomics, MS, Athlete, Nuclear magnetic resonance spectroscopy, Paint, Agilent Technologies, Acquisition, GC-MS, Investment, SAN, Drug discovery, Gas chromatography–mass spectrometry, Growth, Virtual Control, PCR, Red Data Book of Ukraine, Software, Fine chemical, Medical imaging

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.

Key Points: 
  • SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- The global spectrometry industry size will witness robust growth on the back of growing applications across drug development procedures, forensic analysis and proteomics, according to the " Spectrometry Industry Data Book, 2023 - 2030 ," published by Grand View Research.
  • Forward-looking players have upped investments in molecular spectrometry in pharmaceutical and biotechnology in the wake of innovation in infrared (IR) spectroscopy.
  • Equipment manufacturers have injected funds into mass spectrometry (MS) in the drug development pipeline, applied testing, clinical diagnostics and food products.
  • Order your copy of the Free Sample of "Spectrometry Industry Data Book - Spectrometry, Mass Spectrometry, NMR Spectroscopy, Near-Infrared Spectroscopy and In-line UV-vis Spectroscopy Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research
    An uptick in biomedical research has fueled the penetration of nuclear magnetic resonance (NMR) spectroscopy across business verticals.

Global Life Science Instrumentation Market Report 2023: Sector is Expected to Reach $107.3 Billion by 2030 at a CAGR of 6.5% - ResearchAndMarkets.com

Retrieved on: 
Friday, June 16, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Vaccine, Prevalence, Software, Coalition, NGS, Chromatography, Diagnosis, Food quality, MEA, Research, Mass spectrometry, World Bank, USD, Government, Market, Agilent Technologies, Flow cytometry, Hospital, Laboratory, Application, Machine learning, Engineering, Plant growth analysis, Artificial intelligence, Conditional sentence, Virtual Control, Growth, AI, Microscopy, NYSE, PCR, Third-generation sequencing, Management, Medical device, Fine chemical, Health care, Electrophoresis

The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.

Key Points: 
  • The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.
  • Global life science instrumentation market is segmented based on technology, application, distribution channel and region.
  • Based on the application, the global life science instrumentation market is segmented into Clinical and Diagnostic, Research and Others.
  • The growth of the life science instrumentation market is being propelled by several factors including increased government spending in life science research and development in the biotechnology and life science sectors.

Agilent Announced as Instrument Business Outlook 2022 Company of the Year

Retrieved on: 
Monday, March 20, 2023
Technology, Recycling, Professional Services, Environmental, Social and Governance (ESG), Environment, Telecommunications, Sustainability, Software, Networks, Internet, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, ECD, Partnership, GC/MS, Seahorse, Bioinformatics, PSS, Research, Acquisition, Investment, Artificial intelligence, Growth, IBO, Virtual Control, ESG, Helium, Spiral Dynamics, LC/MS, NYSE, Renewable energy, Fine chemical, Agilent Technologies

Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year.
  • Innovations noted included the HydroInert source, which allows for using of hydrogen instead of helium as the carrier gas in GC/MS.
  • Also, the introductions of new versions of the AssayMAP Bravo Protein Sample Prep Workbench and the Seahorse XF Pro Analyzer.
  • Tanya Samazan, managing editor at IBO noted: “Agilent’s achievements were about annual results as well as years of transforming the company.

Global Laboratory Informatics Market Report 2022 to 2032 - Decreasing Cost Due to Increasing Use of Cloud-Based Systems Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022
Medical Devices, Health, Laboratory, LIMS, Amazon Web Services, PerkinElmer, Data management, SOP, Center for Urban and Regional Analysis, Thermo Fisher Scientific, Virtual Control, Mass spectrometry, Agilent Technologies, Abbott, European Technology Platform on Smart Systems Integration, Component, Growth, Informatics, Amazon, AWS, ELN, Deployment, Acquisition, Medical device, Medicine, Online shopping

The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.

Key Points: 
  • The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
  • The growth in the global laboratory informatics market is expected to be driven by the increased efficiency of laboratories due to their usage and better data management.
  • As a result, there has been a significant increase in the need for laboratory informatics adoption at all levels.
  • This expanded usage of laboratory informatics has enabled end customers to describe particular system requirements, prompting suppliers to design more appealing and practical products and feasible laboratory informatics choices.

The Worldwide Laboratory Informatics Industry is Anticipated to Reach $12.6 Billion by 2032: Reduced Human Error and Increased Efficiency is Driving Growth

Retrieved on: 
Tuesday, December 13, 2022
Laboratory, Benchmarking, LIMS, Amazon Web Services, ML, PerkinElmer, Data management, Name, Software, Mindful Scientific Inc., SOP, Agilent Technologies, Center for Urban and Regional Analysis, Thermo Fisher Scientific, Danaher, Virtual Control, Mass spectrometry, Abbott, European Technology Platform on Smart Systems Integration, AI, Component, Face, Polar, Growth, Informatics, Amazon, IDBS, AWS, ELN, Deployment, Acquisition, Medicine, Medical device, Online shopping

The growth in the global laboratory informatics market is expected to be driven by the increased efficiency of laboratories due to their usage and better data management.

Key Points: 
  • The growth in the global laboratory informatics market is expected to be driven by the increased efficiency of laboratories due to their usage and better data management.
  • These advancements indicated that paper-based record keeping and results reporting were impractical and could not serve the laboratory's commercial demands.
  • As a result, there has been a significant increase in the need for laboratory informatics adoption at all levels.
  • This expanded usage of laboratory informatics has enabled end customers to describe particular system requirements, prompting suppliers to design more appealing and practical products and feasible laboratory informatics choices.

Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity

Retrieved on: 
Thursday, February 17, 2022
Software, Biotechnology, Other Manufacturing, Health, Chemicals, Plastics, Technology, Manufacturing, Other Health, NYSE, Quality of life, Risk, Form 10-K, Forward-looking statement, Annual report, LC/MS, U.S. Securities and Exchange Commission, Solution, Mass spectrometry, Security (finance), Efficiency, Securities Exchange Act of 1934, Technology, Virtual Control, LinkedIn, Twitter, Artificial intelligence, Digital technology, Acquisition, Agriculture, Software, Investment, News, 3D printing, Risk management, Facebook, Agilent Technologies

Agilent Technologies Inc. (NYSE: A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that creates innovative analysis solutions in lab testing.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that creates innovative analysis solutions in lab testing.
  • Agilent will integrate the technology into its MassHunter software package for LC/MS and GC/MS instruments.
  • The acquisition is Agilents latest investment in digital technology to improve lab productivity.
  • It builds on the companys existing investments and innovations to advance the analytical lab and transform its capabilities with new technology, better integration of instruments and data, and more efficient lab workflow.